BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23060046)

  • 1. Fragile X-related element 2 methylation analysis may provide a suitable option for inclusion of fragile X syndrome and/or sex chromosome aneuploidy into newborn screening: a technical validation study.
    Inaba Y; Herlihy AS; Schwartz CE; Skinner C; Bui QM; Cobb J; Shi EZ; Francis D; Arvaj A; Amor DJ; Pope K; Wotton T; Cohen J; Hewitt JK; Hagerman RJ; Metcalfe SA; Hopper JL; Loesch DZ; Slater HR; Godler DE
    Genet Med; 2013 Apr; 15(4):290-8. PubMed ID: 23060046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of skewed X-chromosome inactivation in Fragile X syndrome and X chromosome aneuploidy using quantitative melt analysis.
    Godler DE; Inaba Y; Schwartz CE; Bui QM; Shi EZ; Li X; Herlihy AS; Skinner C; Hagerman RJ; Francis D; Amor DJ; Metcalfe SA; Hopper JL; Slater HR
    Expert Rev Mol Med; 2015 Jul; 17():e13. PubMed ID: 26132880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative assessment of FMR1 (CGG)n triplet repeat status in normal, intermediate, premutation, full mutation, and mosaic carriers in both sexes: implications for fragile X syndrome carrier and newborn screening.
    Hantash FM; Goos DG; Tsao D; Quan F; Buller-Burckle A; Peng M; Jarvis M; Sun W; Strom CM
    Genet Med; 2010 Mar; 12(3):162-73. PubMed ID: 20168238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA.
    Coffee B; Keith K; Albizua I; Malone T; Mowrey J; Sherman SL; Warren ST
    Am J Hum Genet; 2009 Oct; 85(4):503-14. PubMed ID: 19804849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragile X mental retardation 1 (FMR1) intron 1 methylation in blood predicts verbal cognitive impairment in female carriers of expanded FMR1 alleles: evidence from a pilot study.
    Godler DE; Slater HR; Bui QM; Storey E; Ono MY; Gehling F; Inaba Y; Francis D; Hopper JL; Kinsella G; Amor DJ; Hagerman RJ; Loesch DZ
    Clin Chem; 2012 Mar; 58(3):590-8. PubMed ID: 22235103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between age and epi-genotype of the FMR1 exon 1/intron 1 boundary are consistent with non-random X-chromosome inactivation in FM individuals, with the selection for the unmethylated state being most significant between birth and puberty.
    Godler DE; Inaba Y; Shi EZ; Skinner C; Bui QM; Francis D; Amor DJ; Hopper JL; Loesch DZ; Hagerman RJ; Schwartz CE; Slater HR
    Hum Mol Genet; 2013 Apr; 22(8):1516-24. PubMed ID: 23307923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of Fragile X Screening in the Newborn Population Using a Fit-for-Purpose FMR1 PCR Assay System.
    Lee S; Taylor JL; Redmond C; Hadd AG; Kemppainen JA; Haynes BC; Shone S; Bailey DB; Latham GJ
    J Mol Diagn; 2020 Mar; 22(3):346-354. PubMed ID: 31866572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FMR1 intron 1 methylation predicts FMRP expression in blood of female carriers of expanded FMR1 alleles.
    Godler DE; Slater HR; Bui QM; Ono M; Gehling F; Francis D; Amor DJ; Hopper JL; Hagerman R; Loesch DZ
    J Mol Diagn; 2011 Sep; 13(5):528-36. PubMed ID: 21723415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio.
    Godler DE; Tassone F; Loesch DZ; Taylor AK; Gehling F; Hagerman RJ; Burgess T; Ganesamoorthy D; Hennerich D; Gordon L; Evans A; Choo KH; Slater HR
    Hum Mol Genet; 2010 Apr; 19(8):1618-32. PubMed ID: 20118148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
    Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
    PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragile X syndrome full mutation in cognitively normal male identified as part of an Australian reproductive carrier screening program.
    Jarmolowicz AI; Baker EK; Bartlett E; Francis D; Ling L; Gamage D; Delatycki MB; Godler DE
    Am J Med Genet A; 2021 May; 185(5):1498-1503. PubMed ID: 33544979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early detection of fragile X syndrome: applications of a novel approach for improved quantitative methylation analysis in venous blood and newborn blood spots.
    Inaba Y; Schwartz CE; Bui QM; Li X; Skinner C; Field M; Wotton T; Hagerman RJ; Francis D; Amor DJ; Hopper JL; Loesch DZ; Bretherton L; Slater HR; Godler DE
    Clin Chem; 2014 Jul; 60(7):963-73. PubMed ID: 24778142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormally Methylated FMR1 in Absence of a Detectable Full Mutation in a U.S.A Patient Cohort Referred for Fragile X Testing.
    Hensel CH; Vanzo RJ; Martin MM; Ling L; Aliaga SM; Bui M; Francis DI; Twede H; Field MH; Morison JW; Amor DJ; Godler DE
    Sci Rep; 2019 Oct; 9(1):15315. PubMed ID: 31653898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Validation of Fragile X Syndrome Screening by DNA Methylation Array.
    Schenkel LC; Schwartz C; Skinner C; Rodenhiser DI; Ainsworth PJ; Pare G; Sadikovic B
    J Mol Diagn; 2016 Nov; 18(6):834-841. PubMed ID: 27585064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assessment of screening strategies for fragile X syndrome in the UK.
    Pembrey ME; Barnicoat AJ; Carmichael B; Bobrow M; Turner G
    Health Technol Assess; 2001; 5(7):1-95. PubMed ID: 11262423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal FMR1 premutation allele expansion and contraction in fraternal twins.
    Alfaro MP; Cohen M; Vnencak-Jones CL
    Am J Med Genet A; 2013 Oct; 161A(10):2620-5. PubMed ID: 23949867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragile X-associated tremor/ataxia syndrome: influence of the FMR1 gene on motor fiber tracts in males with normal and premutation alleles.
    Wang JY; Hessl D; Schneider A; Tassone F; Hagerman RJ; Rivera SM
    JAMA Neurol; 2013 Aug; 70(8):1022-9. PubMed ID: 23753897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome.
    Taylor AK; Safanda JF; Fall MZ; Quince C; Lang KA; Hull CE; Carpenter I; Staley LW; Hagerman RJ
    JAMA; 1994 Feb; 271(7):507-14. PubMed ID: 8301764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the human fragile X mental retardation 1 polymerase chain reaction reagents to amplify the FMR1 gene: testing in a clinical diagnostic laboratory.
    Nahhas FA; Monroe TJ; Prior TW; Botma PI; Fang J; Snyder PJ; Talbott SL; Feldman GL
    Genet Test Mol Biomarkers; 2012 Mar; 16(3):187-92. PubMed ID: 21992462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription of the FMR1 gene in individuals with fragile X syndrome.
    Tassone F; Hagerman RJ; Chamberlain WD; Hagerman PJ
    Am J Med Genet; 2000; 97(3):195-203. PubMed ID: 11449488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.